about
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancermiR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.MicroRNAs: master regulators of drug resistance, stemness, and metastasis.Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.Re-activation of cAMP pathway by PDE4D inhibition represents a novel druggable axis for overcoming tamoxifen resistance in ER-positive breast cancer.Polyol pathway links glucose metabolism to the aggressiveness of cancer cells.Systems biology based meth-miRNA-mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progressionNovel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell deathTargeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
P50
Q28468629-8505569E-C6BD-49E1-858B-06AD33530FB8Q37236236-B416C578-5EFE-4C93-A15B-091A7D5F9BC5Q38186568-990EB945-2431-4AB2-A3E3-7F3E2F3771FBQ48120168-B53F78A4-8437-4FA8-B45F-BBE436FF2E52Q49546274-50C17B7A-5483-426C-84EA-37978BC70BD1Q49990358-D4AE02DA-7174-46F6-B311-FAAF7DBAAEDAQ64066145-0DAAB7CB-AC28-47EF-BA85-C74ADF962D30Q91606421-9C4EE726-AB21-4E36-AF2A-86780DFCC1AAQ94948652-BBF06433-3EC8-4181-BBB8-D58E8412B4F5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Umar Raza
@en
Umar Raza
@nl
type
label
Umar Raza
@en
Umar Raza
@nl
prefLabel
Umar Raza
@en
Umar Raza
@nl
P31
P496
0000-0002-0081-6996